Text Size

Why in Hospital - Factors Determining Time to Discharge Readiness After Arthroplasty Surgery

This study has been completed.
Sponsor:
Collaborator:
Lundbeck Foundation
Information provided by (Responsible Party):
Troels Haxholdt Lunn, Hvidovre University Hospital
ClinicalTrials.gov Identifier:
NCT01047371
First received: January 11, 2010
Last updated: September 28, 2011
Last verified: September 2011
History of Changes
  Purpose

The purpose of this study is to evaluate patient related factors determining length of stay in hospital after arthroplasty surgery.


Condition
Pain
Nausea
Vomiting
Dizzyness
Fatigue
Organizational Concerns
Ect.

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Why in Hospital - Factors Determining Time to Discharge Readiness After Arthroplasty Surgery: An Prospective Observational Study

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Hvidovre University Hospital:

Primary Outcome Measures:
  • Patient related factors determining length of stay in hospital [ Time Frame: Daily (average 2 days) ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Length of stay in hospital [ Time Frame: At discharge (average 2 days) ] [ Designated as safety issue: No ]
  • Time till fulfilling of predefined discharge criteria [ Time Frame: At discharge (average 2 days) ] [ Designated as safety issue: No ]

Estimated Enrollment: 200
Study Start Date: January 2010
Study Completion Date: August 2010
Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
Patients with Osteoarthrosis
All consecutive patients scheduled for total hip or knee arthroplasty

Detailed Description:

To evaluate why the patient is in hospital after surgery, when predefined discharge criteria are met, which patient related clinical problems hinder fulfilling of the discharge criteria, and to evaluate actual length of stay in hospital.

All consecutive patients scheduled for total hip or knee arthroplasty are included in the trial.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

All consecutive patients scheduled for total hip or knee arthroplasty

Criteria

Inclusion Criteria:

  • Patients scheduled for total hip or knee arthroplasty

Exclusion Criteria:

  • Age under 18 years
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01047371

Locations
Denmark
Hvidovre University Hospital
Copenhagen, Hvidovre, Denmark, 2650
Sponsors and Collaborators
Hvidovre University Hospital
Lundbeck Foundation
Investigators
Study Director: Henrik Husted, MD Hvidovre University Hospital
Principal Investigator: Troels H. Lunn, M.D Hvidovre University Hospital
  More Information

No publications provided

Responsible Party: Troels Haxholdt Lunn, MD, Hvidovre University Hospital
ClinicalTrials.gov Identifier: NCT01047371     History of Changes
Other Study ID Numbers: 1234, 5678
Study First Received: January 11, 2010
Last Updated: September 28, 2011
Health Authority: Denmark: Danish Dataprotection Agency

Additional relevant MeSH terms:
Dizziness
Vertigo
Fatigue
Nausea
Vomiting
Sensation Disorders
Neurologic Manifestations
 Nervous System Diseases
Signs and Symptoms
Vestibular Diseases
Labyrinth Diseases
Ear Diseases
Otorhinolaryngologic Diseases
Signs and Symptoms, Digestive

ClinicalTrials.gov processed this record on May 19, 2013